Delivery Order SPE2DB22D3010-SPE2DB24FP2LS
Award Date 5/22/24
Potential Completion Date 5/23/24
Potential Value $2.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Latuda 40 mg tablets (30-count units) valued at $7,754.48 under a firm fixed price contract structure. This non-set-aside award was competitively procured and is scheduled for completion by July 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and will fulfill this order...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company and government contractor. The contract, valued at $1,389.44, is for the delivery of the prescription medication Latuda 40 mg tablet in quantities of 30. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,938.24 firm fixed-price delivery order is for the supply of LATUDA 40 MG TABLET 30S, a pharmaceutical product, with a period of performance through March 31, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4557906066 - LATUDA 40 MG TABLET 30S. The $3,021.95 firm fixed-price delivery order contract has a completion date of July 27, 2022. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,087.12, is for the delivery of 60 mg Latuda tablets (national stock number 4565047371) with a period of performance through July 2, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and the contract is part of a larger...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract was awarded by the Defense Logistics Agency (DLA) and has a value of $3,391.89. It is a delivery order contract for the supply of the pharmaceutical product LATUDA 20 MG TABLET 30S. The contract has an ultimate completion date of November 15, 2024. This contract is not designated as a set-aside and was awarded through open competition....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LATUDA 40 mg tablets. The contract has a total ceiling value of $3,781.70 and runs through August 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with DLA Troop Support Medical for a comprehensive range of medical commodities to support military...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,787.95 to AmerisourceBergen Drug Corp for the supply of Latuda 40 mg tablets (30-count units) under a firm fixed price arrangement. The order was competitively awarded without set-aside designation and is scheduled for completion by May 7, 2025, with performance to be fulfilled at the contractor's Conshohocken, Pennsylvania location. This delivery order represents a child contract action under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of LATUDA 20 MG TABLET 30S. The $6,436.16 award is not associated with any set-aside designation. Amerisourcebergen Drug Corp serves as a prime contractor providing pharmaceutical products and medical supplies to DLA Troop Support Medical in support of military treatment programs and facilities. The company also holds an...
- This federal contract award is between the Defense Logistics Agency (DLA) and Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Latuda 40 mg tablet 30s. The $5,592.70 firm fixed-price delivery order is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract, which does...
- SPE2DB22D3010Indefinite Delivery Contract
- SPE2DB22D3010-SPE2DB24FP2LSDelivery Order
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4564689950 tablets of the medication LATUDA 40 MG. The $2,179.47 contract has a completion date of May 23, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to deliver a broad range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This order is not designated as a set-aside contract.
Generated 8/21/24, 6:56 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 5/22/24 |